(2018). New molecular approches using AR, FOXA1 and HER2 for outcome classification of estrogen Receptor-Positive (ER+) breast cancers”.
Chicago Style (17th ed.) CitationNew Molecular Approches Using AR, FOXA1 and HER2 for Outcome Classification of Estrogen Receptor-Positive (ER+) Breast Cancers”. 2018.
MLA (8th ed.) CitationNew Molecular Approches Using AR, FOXA1 and HER2 for Outcome Classification of Estrogen Receptor-Positive (ER+) Breast Cancers”. 2018.
Warning: These citations may not always be 100% accurate.